Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1714–1718. doi: 10.1158/1055-9965.EPI-08-0088

Table 3.

CRP levels at baseline and 12 months in exercise intervention and control participants: stratified by baseline BMI.

Baseline
Follow-up
n Exercisers Geometric Mean (95% CI) n Controls Geometric Mean (95% CI) n Exercisers Geometric Mean (95% CI) n Controls Geometric Mean (95% CI)
Men
 BMI < 30 kg/m2 26 0.85 (0.63–1.14) 26 0.89 (0.61–1.30) 22 0.82 (0.62–1.08) 26 0.74 (0.54–1.01)
p-value: 0.61
 BMI ≥ 30 kg/m2 23 1.67 (1.24–2.25) 23 1.57 (1.03–2.39) 24 1.80 (1.25–2.59) 25 1.40 (0.92–2.15)
p-value: 0.38
Women
 BMI < 30 kg/m2 29 1.32 (0.88–1.99) 30 1.60 (1.07–2.38) 28 1.27 (0.86–1.89) 29 1.59 (1.04–2.45)
p-value: 0.82
 BMI ≥ 30 kg/m2 19 4.14 (2.68–6.39) 19 3.47 (2.20–5.47) 17 3.54 (2.33–5.38) 19 3.44 (2.29–5.16)
p-value: 0.73

P-value for difference in CRP changes from baseline to twelve months in exercise intervention versus control stratified by BMI group, controlling for baseline CRP values.